Axiom Clinical Research | Enrolling Trials

Enrolling Studies

Axiom is currently enrolling patients in Multiple Sclerosis, Alzheimer’s Disease, Essential Tremor and Migraine studies.

If you or a loved one would be interested in participating in a study for any of the listed fields, or if you would like more information on our studies, please contact us at Marketing.AxiomFL@gmail.com or

813-353-9613.

CURRENTLY ENROLLING STUDIES

Alzheimer's Disease

Learn More

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-Tau Monoclocal Antibody, in Participants with Early Alzheimer's Disease

Multiple Sclerosis

Learn More

A Phase 3, Randomized, Double-Blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Participants with Relapsing Forms of Multiple Sclerosis

A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants with Non-relapsing Secondary Progressive Multiple Sclerosis

A Phase IIIB Multicenter, Randomized, Double-Blind Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis

A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

A Single Arm, Prospective, Multicentre, Open-Label Study to Evaluate Ofatumumab Treatment Effectiveness and Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Transitioning from Dimethyl Fumerate or Fingolimod Therapy

Alzheimer's Disease with Agitation

Learn More

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-786 (deudextromethorphan hydrobromide/quinidine sulfate) for the Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type

Migraine

Learn More

There are no migraine studies currently enrolling at our site. To receive information on future studies, click 'Learn More' to leave your contact information.

Would you like to receive a copy of our quarterly newsletter? Click here to sign up to receive updates on currently enrolling trials, upcoming events, noteworthy news and more.